Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119525234 | 11952523 | 4 | F | 20151112 | 20160822 | 20160126 | 20160902 | EXP | GB-TEVA-626622ACC | TEVA | 67.00 | YR | F | Y | 94.00000 | KG | 20160902 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119525234 | 11952523 | 1 | PS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | DOSAGE FORM: UNSPECIFIED, CYCLE 01 PERIOD | Y | U | UNKNOWN | 89081 | 125 | MG | |||||
119525234 | 11952523 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | DOSAGE FORM: UNSPECIFIED | Y | U | UNKNOWN | 89081 | 5 | MG | |||||
119525234 | 11952523 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | DOSAGE FORM: UNSPECIFIED, CYCLE 3 PERIOD 1 | Y | U | UNKNOWN | 89081 | 120 | MG | |||||
119525234 | 11952523 | 4 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | DOSAGE FORM: UNSPECIFIED, CYCLE 2 PERIOD 1? | Y | U | UNKNOWN | 89081 | 120 | MG | |||||
119525234 | 11952523 | 5 | SS | DARATUMUMAB | DARATUMUMAB | 1 | Intravenous (not otherwise specified) | Y | U | 087965;087966 | 0 | 1570 | MG | SOLUTION FOR INFUSION | |||||
119525234 | 11952523 | 6 | SS | MELPHALAN | MELPHALAN | 1 | Oral | DOSAGE FORM: UNSPECIFIED, CYCLE 01 PERIOD | Y | U | UNKNOWN | 0 | 18 | MG | |||||
119525234 | 11952523 | 7 | SS | MELPHALAN | MELPHALAN | 1 | Oral | DOSAGE FORM: UNSPECIFIED, CYCLE 01 PERIOD | Y | U | UNKNOWN | 0 | 18 | MG | |||||
119525234 | 11952523 | 8 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 02 DAY 1. LABEL IDENTIFIERS: 14463-08 | Y | U | UNKNOWN | 0 | 2.6 | MG | SOLUTION FOR INFUSION | ||||
119525234 | 11952523 | 9 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 01 DAY 4. LABEL IDENTIFIERS: 14463-02 | Y | U | UNKNOWN | 0 | 2.7 | MG | SOLUTION FOR INFUSION | ||||
119525234 | 11952523 | 10 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 01 DAY 29. LABEL IDENTIFIERS: 14463-07 | Y | U | UNKNOWN | 0 | 2.7 | MG | SOLUTION FOR INFUSION | ||||
119525234 | 11952523 | 11 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 01 DAY 25. LABEL IDENTIFIERS: 14463-06 | Y | U | UNKNOWN | 0 | 2.7 | MG | |||||
119525234 | 11952523 | 12 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 01 DAY 1. LABEL IDENTIFIERS: 14463-01 | Y | U | UNKNOWN | 0 | 2.7 | MG | SOLUTION FOR INFUSION | ||||
119525234 | 11952523 | 13 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 01 DAY 11. LABEL IDENTIFIERS: 14463-04 | Y | U | UNKNOWN | 0 | 2.7 | MG | SOLUTION FOR INFUSION | ||||
119525234 | 11952523 | 14 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 01 DAY 8. LABEL IDENTIFIERS: 14463-03 | Y | U | UNKNOWN | 0 | 2.7 | MG | SOLUTION FOR INFUSION | ||||
119525234 | 11952523 | 15 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 01 DAY 22. LABEL IDENTIFIERS: 14463-05 | Y | U | UNKNOWN | 0 | 2.7 | MG | |||||
119525234 | 11952523 | 16 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 3 DAY 1 LABEL IDENTIFIER V14464-03? | Y | U | UNKNOWN | 0 | 2 | MG | |||||
119525234 | 11952523 | 17 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 2 DAY 8 LABEL IDENTIFIER V14463-10 | Y | U | UNKNOWN | 0 | 2.7 | MG | |||||
119525234 | 11952523 | 18 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 2 DAY 29 LABEL IDENTIFIER V14464-02 | Y | U | UNKNOWN | 0 | 2.6 | MG | |||||
119525234 | 11952523 | 19 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | DOSAGE FORM: LYOPHILIZED POWDER, CYCLE 2 DAY 22 LABLE IDENTIFIER V14464-01? | Y | U | UNKNOWN | 0 | 2.6 | MG | |||||
119525234 | 11952523 | 20 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 2.5 MILLIGRAM DAILY; | 0 | 2.5 | MG | TABLET | QD | ||||||
119525234 | 11952523 | 21 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 40 MILLIGRAM DAILY; | 0 | 40 | MG | TABLET | QD | ||||||
119525234 | 11952523 | 22 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 20 | MG | TABLET | ||||||||
119525234 | 11952523 | 23 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | DOSAGE FORM: UNSPECIFIED | 0 | 1.25 | MG | ||||||||
119525234 | 11952523 | 24 | C | BISOPROLOL | BISOPROLOL | 1 | Oral | 2.5 MILLIGRAM DAILY; DOSAGE FORM: TAPE | 0 | 2.5 | MG | TABLET | |||||||
119525234 | 11952523 | 25 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 1000 MILLIGRAM DAILY; DOSAGE FORM: UNSPECIFIED | 0 | 500 | MG | TABLET | BID | ||||||
119525234 | 11952523 | 26 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Oral | 0 | 100 | MG | TABLET | ||||||||
119525234 | 11952523 | 27 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | 0 | ||||||||||||
119525234 | 11952523 | 28 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | 0 | ||||||||||||
119525234 | 11952523 | 29 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | DOSAGE FORM: UNSPECIFIED | 0 | 25 | MG | ||||||||
119525234 | 11952523 | 30 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Other | 50 MILLIGRAM DAILY; DOSAGE FORM: UNSPECIFIED | 0 | 50 | MG | TABLET | |||||||
119525234 | 11952523 | 31 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Other | 75 MILLIGRAM DAILY; | 0 | 75 | MG | TABLET | |||||||
119525234 | 11952523 | 32 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 100 MILLIGRAM DAILY; | 0 | 100 | MG | TABLET | QD | ||||||
119525234 | 11952523 | 33 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MILLIGRAM DAILY; | 0 | 500 | MG | TABLET | BID | ||||||
119525234 | 11952523 | 34 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | TABLET | ||||||||
119525234 | 11952523 | 35 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MILLIGRAM DAILY; | 0 | 20 | MG | TABLET | QD | ||||||
119525234 | 11952523 | 36 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
119525234 | 11952523 | 37 | C | ACICLOVIR? | 2 | Unknown | DOSAGE FORM: UNSPECIFIED? | 0 | |||||||||||
119525234 | 11952523 | 38 | C | ACICLOVIR? | 2 | Unknown | DOSAGE FORM: UNSPECIFIED? | 0 | |||||||||||
119525234 | 11952523 | 39 | C | ACICLOVIR? | 2 | Unknown | DOSAGE FORM: UNSPECIFIED? | 0 | |||||||||||
119525234 | 11952523 | 40 | C | ACICLOVIR? | 2 | Intravenous (not otherwise specified) | 600 MILLIGRAM DAILY; | 0 | 200 | MG | ORAL LIQUID | TID | |||||||
119525234 | 11952523 | 41 | C | ACICLOVIR? | 2 | Oral | 600 MILLIGRAM DAILY; | 0 | 200 | MG | TABLET | TID | |||||||
119525234 | 11952523 | 42 | C | ACICLOVIR? | 2 | Intravenous (not otherwise specified) | 800 MILLIGRAM DAILY; | 0 | 400 | MG | ORAL LIQUID | BID | |||||||
119525234 | 11952523 | 43 | C | ACICLOVIR? | 2 | Intravenous (not otherwise specified) | 1600 MILLIGRAM DAILY; | 0 | 800 | MG | ORAL LIQUID | BID | |||||||
119525234 | 11952523 | 44 | C | ADCAL-D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | Oral | 1 DOSAGE FORMS DAILY; | 0 | 1 | DF | TABLET | |||||||
119525234 | 11952523 | 45 | C | ADCAL-D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | 0 | ||||||||||||
119525234 | 11952523 | 46 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MILLIGRAM DAILY; | 0 | 300 | MG | TABLET | |||||||
119525234 | 11952523 | 47 | C | AMIKACIN | AMIKACIN | 1 | Intravenous (not otherwise specified) | 650 MILLIGRAM DAILY; DOSAGE FORM: UNSPECIFIED | 0 | 650 | MG | ORAL LIQUID | |||||||
119525234 | 11952523 | 48 | C | AMIODARONE? | 2 | Intravenous (not otherwise specified) | DOSAGE FORM: UNSPECIFIED | 0 | 25 | MG | ORAL LIQUID | ||||||||
119525234 | 11952523 | 49 | C | ASPIRIN? | 2 | Oral | DOSAGE FORM: UNSPECIFIED? | 0 | 75 | MG | TABLET | ||||||||
119525234 | 11952523 | 50 | C | ASPIRIN? | 2 | Unknown | DOSAGE FORM: UNSPECIFIED | 0 | |||||||||||
119525234 | 11952523 | 51 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | 2000 MILLIGRAM DAILY; DOSAGE FORM: INHALATION | 0 | 500 | MG | TABLET | QID | ||||||
119525234 | 11952523 | 52 | C | AUGMENTIN? | 2 | Unknown | DOSAGE FORM: UNSPECIFIED | 0 | TABLET | ||||||||||
119525234 | 11952523 | 53 | C | AUGMENTIN? | 2 | Oral | 1000 MILLIGRAM DAILY; | 0 | 500 | MG | TABLET | BID | |||||||
119525234 | 11952523 | 54 | C | CARBOCISTEINE? | 2 | Other | 2250 MILLIGRAM DAILY; DOSAGE FORM: UNSPECIFIED? | 0 | 750 | MG | TABLET | TID | |||||||
119525234 | 11952523 | 55 | C | CARBOCISTEINE? | 2 | 0 | |||||||||||||
119525234 | 11952523 | 56 | C | CEFTRIAXONE. | CEFTRIAXONE | 1 | Intravenous (not otherwise specified) | 2000 MILLIGRAM DAILY; DOSAGE FORM: UNSPECIFIED | 0 | 2000 | MG | ORAL LIQUID | |||||||
119525234 | 11952523 | 57 | C | CLONIDINE. | CLONIDINE | 1 | Intravenous (not otherwise specified) | 750 MILLIGRAM DAILY; DOSAGE FORM: UNSPECIFIED | 0 | 750 | MG | ORAL LIQUID | |||||||
119525234 | 11952523 | 58 | C | CO-AMOXICLAV | AMOXICILLINCLAVULANIC ACID | 1 | Oral | 2500 MILLIGRAM DAILY; | 0 | 625 | MG | TABLET | QID | ||||||
119525234 | 11952523 | 59 | C | CO-AMOXICLAV | AMOXICILLINCLAVULANIC ACID | 1 | 0 | ||||||||||||
119525234 | 11952523 | 60 | C | CYCLIZINE | CYCLIZINE | 1 | Intravenous (not otherwise specified) | 150 MILLIGRAM DAILY; | 0 | 50 | MG | ORAL LIQUID | TID | ||||||
119525234 | 11952523 | 61 | C | CYCLIZINE | CYCLIZINE | 1 | 0 | ||||||||||||
119525234 | 11952523 | 62 | C | FENTANYL. | FENTANYL | 1 | Intravenous (not otherwise specified) | 2500 MICROGRAM DAILY; DOSAGE FORM: UNSPECIFIED? | 0 | 2500 | UG | ORAL LIQUID | |||||||
119525234 | 11952523 | 63 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 4 GRAM DAILY; | 0 | 1 | G | TABLET | QID | ||||||
119525234 | 11952523 | 64 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Intravenous (not otherwise specified) | 400 MILLIGRAM DAILY; | 0 | 400 | MG | ORAL LIQUID | |||||||
119525234 | 11952523 | 65 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 5 MILLIGRAM DAILY; | 0 | 5 | MG | ORAL LIQUID | QD | ||||||
119525234 | 11952523 | 66 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
119525234 | 11952523 | 67 | C | FONDAPARINUX? | 2 | Subcutaneous | 2.5 MILLIGRAM DAILY; | 0 | 2.5 | MG | ORAL LIQUID | ||||||||
119525234 | 11952523 | 68 | C | FONDAPARINUX? | 2 | 0 | |||||||||||||
119525234 | 11952523 | 69 | C | FUROSEMIDE? | 2 | Intravenous (not otherwise specified) | 40 MILLIGRAM DAILY; | 0 | 40 | MG | ORAL LIQUID | ||||||||
119525234 | 11952523 | 70 | C | FUROSEMIDE? | 2 | Oral | 40 MILLIGRAM DAILY; | 0 | 40 | MG | TABLET | ||||||||
119525234 | 11952523 | 71 | C | GLUCOSE | DEXTROSE | 1 | Intravenous (not otherwise specified) | 0 | ORAL LIQUID | ||||||||||
119525234 | 11952523 | 72 | C | HYDROCORTISONE? | 2 | Intravenous (not otherwise specified) | 200 MILLIGRAM DAILY; | 0 | 50 | MG | ORAL LIQUID | QID | |||||||
119525234 | 11952523 | 73 | C | HYDROCORTISONE? | 2 | Intravenous (not otherwise specified) | 100 MILLIGRAM DAILY; | 0 | 50 | MG | ORAL LIQUID | BID | |||||||
119525234 | 11952523 | 74 | C | INSULIN | INSULIN NOS | 1 | Intravenous (not otherwise specified) | 0 | ORAL LIQUID | ||||||||||
119525234 | 11952523 | 75 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Other | 30 MILLIGRAM DAILY; | 0 | 30 | MG | TABLET | QD | ||||||
119525234 | 11952523 | 76 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
119525234 | 11952523 | 77 | C | MAGNESIUM GLYCEROPHOSPHATE? | 2 | Oral | 20 ML DAILY; DOSAGE FORM: UNSPECIFIED | 0 | 10 | ML | ORAL LIQUID | BID | |||||||
119525234 | 11952523 | 78 | C | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | 4000 MILLIGRAM DAILY; | 0 | 1000 | MG | ORAL LIQUID | QID | ||||||
119525234 | 11952523 | 79 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 50 MILLIGRAM DAILY; | 0 | 50 | MG | ORAL LIQUID | |||||||
119525234 | 11952523 | 80 | C | NORADRENALIN | NOREPINEPHRINENOREPINEPHRINE BITARTRATE | 1 | Intravenous (not otherwise specified) | 0 | 8 | MG | ORAL LIQUID | ||||||||
119525234 | 11952523 | 81 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | Unknown | DOSAGE FORM: UNSPECIFIED | 0 | ||||||||||
119525234 | 11952523 | 82 | C | ONDANSETRON | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 24 MILLIGRAM DAILY; DOSAGE FORM: UNSPECIFIED | 0 | 8 | MG | ORAL LIQUID | TID | ||||||
119525234 | 11952523 | 83 | C | ONDANSETRON | ONDANSETRON | 1 | 0 | ||||||||||||
119525234 | 11952523 | 84 | C | OSELTAMIVIR | OSELTAMIVIR | 1 | Oral | 150 MILLIGRAM DAILY; | 0 | 75 | MG | TABLET | BID | ||||||
119525234 | 11952523 | 85 | C | OXYCONTIN? | 2 | Oral | 10 MILLIGRAM DAILY; DOSAGE FORM: UNSPECIFIED | 0 | 5 | MG | ORAL LIQUID | BID | |||||||
119525234 | 11952523 | 86 | C | OXYNORM? | 2 | Oral | 0 | 5 | MG | TABLET | |||||||||
119525234 | 11952523 | 87 | C | PARACETAMOL? | 2 | Oral | 4 GRAM DAILY; DOSAGE FORM: UNSPECIFIED? | 0 | 1 | G | TABLET | QID | |||||||
119525234 | 11952523 | 88 | C | POTASSIUM PHOSPHATE | POTASSIUM PHOSPHATE | 1 | Intravenous (not otherwise specified) | 1000 ML DAILY; | 0 | 1000 | ML | ORAL LIQUID | |||||||
119525234 | 11952523 | 89 | C | POTASSIUM PHOSPHATE | POTASSIUM PHOSPHATE | 1 | 0 | ||||||||||||
119525234 | 11952523 | 90 | C | REMIFENTANIL? | 2 | Intravenous (not otherwise specified) | 2 MILLIGRAM DAILY; | 0 | 2 | MG | ORAL LIQUID | ||||||||
119525234 | 11952523 | 91 | C | SENNA? | 2 | Oral | DOSAGE FORM: UNSPECIFIED | 0 | 1 | DF | TABLET | ||||||||
119525234 | 11952523 | 92 | C | TEICOPLANIN | TEICOPLANIN | 1 | Intravenous (not otherwise specified) | 1 GRAM DAILY; | 0 | 1 | G | ORAL LIQUID | |||||||
119525234 | 11952523 | 93 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Oral | DOSAGE FORM: UNSPECIFIED? | 0 | 1 | DF | TABLET | |||||||
119525234 | 11952523 | 94 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | 0 | ||||||||||||
119525234 | 11952523 | 95 | C | ZOMETA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 0 | 4 | MG | ORAL LIQUID | ||||||||
119525234 | 11952523 | 96 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | 1000 MILLIGRAM DAILY; | 0 | 500 | MG | CAPSULE | BID | ||||||
119525234 | 11952523 | 97 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | 0 | ||||||||||||
119525234 | 11952523 | 98 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MILLIGRAM DAILY; | 0 | 75 | MG | TABLET | |||||||
119525234 | 11952523 | 99 | C | AMOXICILLIN. | AMOXICILLIN | 1 | Oral | 750 MILLIGRAM DAILY; | 0 | 250 | MG | CAPSULE | TID | ||||||
119525234 | 11952523 | 100 | C | CO-DYDRAMOL | ACETAMINOPHENDIHYDROCODEINE | 1 | Oral | 0 | TABLET | ||||||||||
119525234 | 11952523 | 101 | C | CODEINE | CODEINE | 1 | Oral | 120 MILLIGRAM DAILY; | 0 | 30 | MG | TABLET | QID | ||||||
119525234 | 11952523 | 102 | C | LIDOCAINE? | 2 | Topical | 0 | 1 | DF | TRANSDERMAL PATCH | |||||||||
119525234 | 11952523 | 103 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 4 DOSAGE FORMS DAILY; | 0 | 1 | DF | TABLET | QID | ||||||
119525234 | 11952523 | 104 | C | POTASSIUM CHLORIDE? | 2 | Intravenous (not otherwise specified) | 0 | 400 | ML | ORAL LIQUID | |||||||||
119525234 | 11952523 | 105 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 0 | 5 | MG | TABLET | ||||||||
119525234 | 11952523 | 106 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | DOSAGE FORM: UNSPECIFIED | 0 | ORAL LIQUID | |||||||||
119525234 | 11952523 | 107 | C | SALBUTAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | 20 MILLIGRAM DAILY; DOSAGE FORM: INHALATION | 0 | 5 | MG | ORAL LIQUID | QID | ||||||
119525234 | 11952523 | 108 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 100 MILLIGRAM DAILY; | 0 | 100 | MG | ORAL LIQUID | |||||||
119525234 | 11952523 | 109 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Oral | 13.5 GRAM DAILY; | 0 | 4.5 | G | TABLET | TID | ||||||
119525234 | 11952523 | 110 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 13.5 MILLIGRAM DAILY; DOSAGE FORM: POWDER? | 0 | 4.5 | MG | CAPSULE | TID | ||||||
119525234 | 11952523 | 111 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Intravenous (not otherwise specified) | 0 | 1 | MG | ORAL LIQUID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119525234 | 11952523 | 1 | Plasma cell myeloma |
119525234 | 11952523 | 2 | Upper respiratory tract infection |
119525234 | 11952523 | 5 | Plasma cell myeloma |
119525234 | 11952523 | 6 | Plasma cell myeloma |
119525234 | 11952523 | 8 | Plasma cell myeloma |
119525234 | 11952523 | 20 | Hypertension |
119525234 | 11952523 | 21 | Blood cholesterol |
119525234 | 11952523 | 22 | Prophylaxis |
119525234 | 11952523 | 23 | Hypertension |
119525234 | 11952523 | 25 | Infection prophylaxis |
119525234 | 11952523 | 26 | Upper respiratory tract infection |
119525234 | 11952523 | 27 | Prophylaxis |
119525234 | 11952523 | 28 | Upper respiratory tract infection |
119525234 | 11952523 | 29 | Hypothyroidism |
119525234 | 11952523 | 30 | Prophylaxis |
119525234 | 11952523 | 32 | Hypertension |
119525234 | 11952523 | 33 | Type 2 diabetes mellitus |
119525234 | 11952523 | 35 | Antacid therapy |
119525234 | 11952523 | 36 | Gastrooesophageal reflux disease |
119525234 | 11952523 | 37 | Prophylaxis |
119525234 | 11952523 | 38 | Acute coronary syndrome |
119525234 | 11952523 | 39 | Sepsis |
119525234 | 11952523 | 44 | Prophylaxis |
119525234 | 11952523 | 45 | Hypocalcaemia |
119525234 | 11952523 | 46 | Prophylaxis |
119525234 | 11952523 | 47 | Sepsis |
119525234 | 11952523 | 48 | Acute coronary syndrome |
119525234 | 11952523 | 49 | Sepsis |
119525234 | 11952523 | 50 | Acute coronary syndrome |
119525234 | 11952523 | 51 | Chronic obstructive pulmonary disease |
119525234 | 11952523 | 52 | Lower respiratory tract infection |
119525234 | 11952523 | 54 | Prophylaxis |
119525234 | 11952523 | 55 | Cough |
119525234 | 11952523 | 56 | Sepsis |
119525234 | 11952523 | 57 | Hypertension |
119525234 | 11952523 | 58 | Prophylaxis |
119525234 | 11952523 | 59 | Lower respiratory tract infection |
119525234 | 11952523 | 60 | Prophylaxis |
119525234 | 11952523 | 61 | Nausea |
119525234 | 11952523 | 62 | Pain in extremity |
119525234 | 11952523 | 63 | Back pain |
119525234 | 11952523 | 64 | Sepsis |
119525234 | 11952523 | 65 | Prophylaxis |
119525234 | 11952523 | 66 | Macrocytosis |
119525234 | 11952523 | 67 | Prophylaxis |
119525234 | 11952523 | 68 | Thrombosis prophylaxis |
119525234 | 11952523 | 69 | Peripheral swelling |
119525234 | 11952523 | 71 | Type 2 diabetes mellitus |
119525234 | 11952523 | 72 | Prophylaxis |
119525234 | 11952523 | 73 | Eczema |
119525234 | 11952523 | 74 | Type 2 diabetes mellitus |
119525234 | 11952523 | 75 | Prophylaxis |
119525234 | 11952523 | 76 | Dyspepsia |
119525234 | 11952523 | 77 | Hypomagnesaemia |
119525234 | 11952523 | 78 | Sepsis |
119525234 | 11952523 | 79 | Pain in extremity |
119525234 | 11952523 | 80 | Acute coronary syndrome |
119525234 | 11952523 | 81 | Prophylaxis |
119525234 | 11952523 | 82 | Prophylaxis |
119525234 | 11952523 | 83 | Nausea |
119525234 | 11952523 | 84 | Sepsis |
119525234 | 11952523 | 85 | Neuropathy peripheral |
119525234 | 11952523 | 86 | Neuropathy peripheral |
119525234 | 11952523 | 87 | Back pain |
119525234 | 11952523 | 88 | Prophylaxis |
119525234 | 11952523 | 89 | Dehydration |
119525234 | 11952523 | 90 | Pain in extremity |
119525234 | 11952523 | 91 | Constipation |
119525234 | 11952523 | 92 | Sepsis |
119525234 | 11952523 | 93 | Prophylaxis |
119525234 | 11952523 | 94 | Neuropathy peripheral |
119525234 | 11952523 | 95 | Plasma cell myeloma |
119525234 | 11952523 | 96 | Lower respiratory tract infection |
119525234 | 11952523 | 97 | Sepsis |
119525234 | 11952523 | 98 | Sepsis |
119525234 | 11952523 | 99 | Lower respiratory tract infection |
119525234 | 11952523 | 100 | Back pain |
119525234 | 11952523 | 101 | Lower respiratory tract infection |
119525234 | 11952523 | 102 | Pain |
119525234 | 11952523 | 103 | Hypomagnesaemia |
119525234 | 11952523 | 104 | Hypokalaemia |
119525234 | 11952523 | 105 | Upper respiratory tract infection |
119525234 | 11952523 | 106 | Prophylaxis |
119525234 | 11952523 | 107 | Chronic obstructive pulmonary disease |
119525234 | 11952523 | 108 | Acute coronary syndrome |
119525234 | 11952523 | 109 | Lower respiratory tract infection |
119525234 | 11952523 | 110 | Sepsis |
119525234 | 11952523 | 111 | Macrocytosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
119525234 | 11952523 | OT |
119525234 | 11952523 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119525234 | 11952523 | Abdominal pain | |
119525234 | 11952523 | Acute coronary syndrome | |
119525234 | 11952523 | Acute kidney injury | |
119525234 | 11952523 | Atrial fibrillation | |
119525234 | 11952523 | Back pain | |
119525234 | 11952523 | Chronic obstructive pulmonary disease | |
119525234 | 11952523 | Constipation | |
119525234 | 11952523 | Lower respiratory tract infection | |
119525234 | 11952523 | Neuropathy peripheral | |
119525234 | 11952523 | Neutropenia | |
119525234 | 11952523 | Peripheral swelling | |
119525234 | 11952523 | Sepsis | |
119525234 | 11952523 | Spinal column stenosis | |
119525234 | 11952523 | Upper respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
119525234 | 11952523 | 1 | 20151102 | 20151105 | 0 | |
119525234 | 11952523 | 2 | 2011 | 0 | ||
119525234 | 11952523 | 3 | 20160202 | 20160204 | 0 | |
119525234 | 11952523 | 4 | 20151222 | 20151224 | 0 | |
119525234 | 11952523 | 5 | 20151102 | 20160201 | 0 | |
119525234 | 11952523 | 6 | 20151102 | 20160201 | 0 | |
119525234 | 11952523 | 7 | 20160201 | 20160204 | 0 | |
119525234 | 11952523 | 8 | 20151222 | 20151222 | 0 | |
119525234 | 11952523 | 9 | 20151105 | 20151105 | 0 | |
119525234 | 11952523 | 10 | 20151130 | 20151130 | 0 | |
119525234 | 11952523 | 11 | 20151126 | 20151126 | 0 | |
119525234 | 11952523 | 12 | 20151102 | 20151102 | 0 | |
119525234 | 11952523 | 13 | 20151112 | 20151112 | 0 | |
119525234 | 11952523 | 14 | 20151109 | 20151109 | 0 | |
119525234 | 11952523 | 15 | 20151123 | 20151123 | 0 | |
119525234 | 11952523 | 16 | 20160201 | 20160201 | 0 | |
119525234 | 11952523 | 17 | 20151229 | 20151229 | 0 | |
119525234 | 11952523 | 18 | 20160118 | 20160118 | 0 | |
119525234 | 11952523 | 19 | 20160111 | 20160111 | 0 | |
119525234 | 11952523 | 20 | 2005 | 20051207 | 0 | |
119525234 | 11952523 | 21 | 2005 | 20151207 | 0 | |
119525234 | 11952523 | 22 | 20160205 | 0 | ||
119525234 | 11952523 | 23 | 2009 | 0 | ||
119525234 | 11952523 | 24 | 2009 | 20160205 | 0 | |
119525234 | 11952523 | 25 | 20151113 | 0 | ||
119525234 | 11952523 | 26 | 2011 | 0 | ||
119525234 | 11952523 | 30 | 1995 | 0 | ||
119525234 | 11952523 | 31 | 20160205 | 0 | ||
119525234 | 11952523 | 32 | 2010 | 0 | ||
119525234 | 11952523 | 33 | 2011 | 20160212 | 0 | |
119525234 | 11952523 | 34 | 20160213 | 0 | ||
119525234 | 11952523 | 35 | 2011 | 0 | ||
119525234 | 11952523 | 40 | 20160212 | 0 | ||
119525234 | 11952523 | 41 | 20160212 | 0 | ||
119525234 | 11952523 | 42 | 20151205 | 20151216 | 0 | |
119525234 | 11952523 | 43 | 20160204 | 20160212 | 0 | |
119525234 | 11952523 | 44 | 20160129 | 0 | ||
119525234 | 11952523 | 46 | 20151205 | 0 | ||
119525234 | 11952523 | 47 | 20160205 | 20160208 | 0 | |
119525234 | 11952523 | 48 | 20160207 | 20160211 | 0 | |
119525234 | 11952523 | 49 | 20160205 | 20160215 | 0 | |
119525234 | 11952523 | 51 | 20160212 | 0 | ||
119525234 | 11952523 | 53 | 20151205 | 20151210 | 0 | |
119525234 | 11952523 | 54 | 20160207 | 20160405 | 0 | |
119525234 | 11952523 | 56 | 20160208 | 0 | ||
119525234 | 11952523 | 57 | 20160209 | 0 | ||
119525234 | 11952523 | 58 | 20151205 | 20151212 | 0 | |
119525234 | 11952523 | 60 | 20151206 | 20151210 | 0 | |
119525234 | 11952523 | 62 | 20160205 | 0 | ||
119525234 | 11952523 | 63 | 20151204 | 0 | ||
119525234 | 11952523 | 64 | 20160204 | 20160212 | 0 | |
119525234 | 11952523 | 65 | 20160129 | 0 | ||
119525234 | 11952523 | 67 | 20160205 | 201602 | 0 | |
119525234 | 11952523 | 69 | 20160111 | 20160111 | 0 | |
119525234 | 11952523 | 70 | 20160112 | 20160229 | 0 | |
119525234 | 11952523 | 71 | 20160204 | 0 | ||
119525234 | 11952523 | 72 | 20160205 | 20160211 | 0 | |
119525234 | 11952523 | 73 | 20160212 | 0 | ||
119525234 | 11952523 | 74 | 20160204 | 0 | ||
119525234 | 11952523 | 75 | 20160204 | 0 | ||
119525234 | 11952523 | 77 | 20160129 | 0 | ||
119525234 | 11952523 | 78 | 20160205 | 20160208 | 0 | |
119525234 | 11952523 | 79 | 20160205 | 0 | ||
119525234 | 11952523 | 80 | 20160204 | 20160208 | 0 | |
119525234 | 11952523 | 82 | 20151206 | 20151210 | 0 | |
119525234 | 11952523 | 84 | 20160204 | 20160215 | 0 | |
119525234 | 11952523 | 85 | 20160129 | 0 | ||
119525234 | 11952523 | 86 | 20160129 | 0 | ||
119525234 | 11952523 | 87 | 20151204 | 0 | ||
119525234 | 11952523 | 88 | 20160204 | 0 | ||
119525234 | 11952523 | 90 | 20160208 | 0 | ||
119525234 | 11952523 | 91 | 20151204 | 0 | ||
119525234 | 11952523 | 92 | 20160204 | 20160211 | 0 | |
119525234 | 11952523 | 93 | 20160129 | 0 | ||
119525234 | 11952523 | 95 | 20160131 | 0 | ||
119525234 | 11952523 | 96 | 20151204 | 20151210 | 0 | |
119525234 | 11952523 | 98 | 20160208 | 20160211 | 0 | |
119525234 | 11952523 | 99 | 20151204 | 20151204 | 0 | |
119525234 | 11952523 | 100 | 20151114 | 0 | ||
119525234 | 11952523 | 101 | 20151216 | 20151230 | 0 | |
119525234 | 11952523 | 102 | 20151216 | 20151217 | 0 | |
119525234 | 11952523 | 103 | 20151205 | 20151216 | 0 | |
119525234 | 11952523 | 104 | 20160215 | 0 | ||
119525234 | 11952523 | 105 | 2011 | 0 | ||
119525234 | 11952523 | 107 | 20160212 | 0 | ||
119525234 | 11952523 | 108 | 20160229 | 20160405 | 0 | |
119525234 | 11952523 | 109 | 20151203 | 20151210 | 0 | |
119525234 | 11952523 | 110 | 20160204 | 20160208 | 0 | |
119525234 | 11952523 | 111 | 20160201 | 20160201 | 0 |